Stock Scorecard
Stock Summary for Incyte Corp (INCY) - $127.22 as of 8/21/2026 12:59:48 PM EST
Total Score
20 out of 30
Safety Score
68 out of 100
Currently on the following lists
Growth Stock List
Tim's Recommendation
Buy
Growth List Algorithm Criteria for INCY
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for INCY
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for INCY
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for INCY
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for INCY (68 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 8 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 6 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 8 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for INCY
Financial Details for INCY
Company Overview |
|
|---|---|
| Ticker | INCY |
| Company Name | Incyte Corp |
| Country | USA |
| Description | Incyte Corp is an American pharmaceutical company based in Alapocas, Delaware. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 6/30/2026 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 127.22 |
| Price 4 Years Ago | 80.32 |
| Last Day Price Updated | 8/21/2026 12:59:48 PM EST |
| Last Day Volume | 1,207,144 |
| Average Daily Volume | 1,743,185 |
| 52-Week High | 132.60 |
| 52-Week Low | 81.09 |
| Last Price to 52 Week Low | 56.89% |
Valuation Measures |
|
| Trailing PE | 16.37 |
| Industry PE | 31.10 |
| Sector PE | 65.79 |
| 5-Year Average PE | 27.64 |
| Free Cash Flow Ratio | 6.47 |
| Industry Free Cash Flow Ratio | 35.50 |
| Sector Free Cash Flow Ratio | 34.78 |
| Current Ratio Most Recent Quarter | 4.66 |
| Total Cash Per Share | 19.65 |
| Book Value Per Share Most Recent Quarter | 31.57 |
| Price to Book Ratio | 4.10 |
| Industry Price to Book Ratio | 13.04 |
| Sector Price to Book Ratio | 13.55 |
| Price to Sales Ratio Twelve Trailing Months | 4.43 |
| Industry Price to Sales Ratio Twelve Trailing Months | 52.60 |
| Sector Price to Sales Ratio Twelve Trailing Months | 22.58 |
| Analyst Buy Ratings | 9 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 202,698,000 |
| Market Capitalization | 25,787,239,560 |
| Institutional Ownership | 103.82% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.59% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 37.70% |
| Annual Earnings Growth | 3,844.96% |
| Reported EPS 12 Trailing Months | 7.77 |
| Reported EPS Past Year | 4.61 |
| Reported EPS Prior Year | 6.79 |
| Net Income Twelve Trailing Months | 1,612,383,000 |
| Net Income Past Year | 1,286,650,000 |
| Net Income Prior Year | 32,615,000 |
| Quarterly Revenue Growth YOY | 37.70% |
| 5-Year Revenue Growth | 14.03% |
| Operating Margin Twelve Trailing Months | 41.90% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 3,982,375,000 |
| Total Cash Past Year | 3,097,817,000 |
| Total Cash Prior Year | 1,687,829,000 |
| Net Cash Position Most Recent Quarter | 3,948,833,000 |
| Net Cash Position Past Year | 3,064,275,000 |
| Long Term Debt Past Year | 33,542,000 |
| Long Term Debt Prior Year | 33,542,000 |
| Total Debt Most Recent Quarter | 33,542,000 |
| Equity to Debt Ratio Past Year | 0.99 |
| Equity to Debt Ratio Most Recent Quarter | 0.99 |
| Total Stockholder Equity Past Year | 5,167,478,000 |
| Total Stockholder Equity Prior Year | 3,447,628,000 |
| Total Stockholder Equity Most Recent Quarter | 6,344,427,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 1,920,466,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 9.47 |
| Free Cash Flow Past Year | 1,354,631,000 |
| Free Cash Flow Prior Year | 249,074,000 |
Options |
|
| Put/Call Ratio | 0.09 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 85.79 |
| 20-Day Bollinger Middle Band | 106.06 |
| 20-Day Bollinger Upper Band | 126.32 |
| Beta | 0.77 |
| RSI | 0.00 |
| 50-Day SMA | 99.71 |
| 150-Day SMA | 75.86 |
| 200-Day SMA | 74.75 |
System |
|
| Modified | 8/21/2026 9:13:20 PM EST |